BEFORE / AFTER dutasteride and minoxidil 5% 1/12/2026
A user shared their positive experience using dutasteride 0.5 mg and minoxidil 5% for hair loss, noting significant improvement in 3 months without side effects. They used Avodart for dutasteride and Costco's minoxidil, taking dutasteride pills every other day and applying topical minoxidil.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity M30, month 2 of dutasteride and minoxidil
A user shared their two-month progress using dutasteride, minoxidil, ketoconazole shampoo, and tretinoin cream for hair loss, reporting no side effects and increased sex drive. Other users discussed their experiences with similar treatments, including finasteride and oral minoxidil, and debated the effectiveness of microneedling.
community Dr Kyle Gillett on topical Dutasteride
The potential effectiveness of topical dutasteride, as well as other hair loss treatments such as finasteride, RU58841, minoxidil, and various vitamins. Experiences from users who have used these treatments were shared.
community Why don't we all just take 2.5mg dutasteride?
Switching from finasteride and minoxidil to a higher dose of dutasteride for hair loss is debated due to potential side effects. Many suggest starting with lower doses or sticking to finasteride if effective.
community Husband (35) is thinning on top, he doesn't know yet. Trying to research so he won't feel so lost or upset when I tell him. Help a girl out?
A woman is concerned about her husband's hair thinning and researches treatments like finasteride and minoxidil. He decides against medication due to potential side effects and plans to shave his head if necessary.
community Reversing 8 years of hair loss. Dut is freaking magic!
A user successfully reversed hair loss over 17 months using 0.5mg dutasteride and 5mg oral minoxidil daily, noting significant improvement without a transplant. Minor side effects like headaches and testicular discomfort were reported but resolved quickly.
Related Research
6 / 6 results
research Nanostructured Drug Delivery Systems for Targeting 5-α-Reductase Inhibitors to the Hair Follicle
This review examines new formulations for delivering 5-α-reductase inhibitors to improve targeted drug delivery in androgenetic alopecia, but reports no new clinical results.
research Lipid nanocarriers as innovative strategies for hair regrowth
This review discusses current treatment strategies for alopecia and highlights the potential of lipid-based nanoparticles to improve drug delivery to the scalp and hair follicles, noting their ability to enhance skin penetration and drug stability while outlining associated challenges and the need for further research.
research Comparative Efficacy of Minoxidil and 5‐Alpha Reductase Inhibitors Monotherapy for Male Pattern Hair Loss: Network Meta‐Analysis Study of Current Empirical Evidence
This study found that among various treatments for male androgenetic alopecia, dutasteride 0.5 mg/day was the most effective option overall. Additionally, among FDA-approved treatments, topical minoxidil 5% was the most effective topical therapy, and finasteride 1 mg/day was the most effective oral therapy.
research Evaluation of the efficacy and safety of topical and oral treatments on hormonal and androgenetic alopecia
This study suggests that a combination of topical minoxidil with oral finasteride or dutasteride promotes hair growth in treating androgenetic alopecia, with only minor safety concerns reported.
research Expert consensus for prevention, diagnosis and management of persistent chemotherapy-induced alopecia.
In this Delphi study, international experts established consensus-based guidelines for diagnosing and managing persistent chemotherapy-induced alopecia (pCIA), recommending prevention through scalp cooling and early use of minoxidil, while advising against bicalutamide and certain finasterides for breast cancer patients due to safety concerns.
research Hair Loss in Women
This review discusses the classifications, diagnostic methods, and treatment strategies for female pattern hair loss, but reports no clinical results.